Location History:
- San Francisco, CA (US) (2011)
- La Jolla, CA (US) (2012)
Company Filing History:
Years Active: 2011-2012
Title: The Innovative Contributions of Ali Razai
Introduction
Ali Razai is a prominent inventor based in La Jolla, California. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic monoclonal antibodies. With a total of 3 patents to his name, Razai's work is paving the way for advancements in medical treatments.
Latest Patents
One of Razai's latest patents focuses on therapeutic monoclonal antibodies that neutralize botulinum neurotoxins. This invention provides antibodies that specifically bind to and neutralize botulinum neurotoxin type A (BoNT/A) and the epitopes bound by those antibodies. The antibodies and derivatives thereof, along with other antibodies that specifically bind to the neutralizing epitopes, can be used to neutralize botulinum neurotoxin. Therefore, these innovations are also useful in the treatment of botulism.
Career Highlights
Ali Razai is affiliated with the University of California, where he continues to engage in groundbreaking research. His work has garnered attention for its potential impact on public health and safety.
Collaborations
Razai collaborates with notable colleagues, including James David Marks and Peter Amersdorfer. Their combined expertise enhances the research and development of innovative solutions in biotechnology.
Conclusion
Ali Razai's contributions to the field of biotechnology through his patents and collaborations highlight his role as a leading inventor. His work on therapeutic monoclonal antibodies represents a significant advancement in the treatment of botulism and showcases the importance of innovation in medicine.